Intraocular Lymphoma

• CLINICAL_TRIALS research · 2025-09-16
  Clinical Trial Update: Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

  This clinical trial update from the Singapore National Eye Centre reports demographics and clinical characteristics of ocular inflammatory d…

• CLINICAL_TRIALS research · 2025-05-20
  Clinical Trial Update: ZR-MTX for PIOL Phase II Trial [Phase 2]

  A Phase II trial evaluating ZR-MTX for primary intraocular lymphoma has not yet recruited.

• CLINICAL_TRIALS trial_result · 2022-04-14
  Clinical Trial Update: Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma [Phase 2]

  Phase 2 trial update for ibrutinib in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma.

• CLINICAL_TRIALS trial_result · 2019-10-09
  Clinical Trial Update: Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma [Phase 2]

  Phase 2 trial investigating intravitreal methotrexate with a Rituximab and Lenalidomide regimen for newly diagnosed primary vitreoretinal ly…

• CLINICAL_TRIALS trial_result · 2017-05-22
  Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]

  Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-02-16
  Clinical Trial Update: A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma [Phase 1]

  A Phase 1 safety study evaluating the intrathecal combination of rituximab and methotrexate for central nervous system lymphoma and intraocu…

• CLINICAL_TRIALS trial_result · 2014-02-24
  Clinical Trial Update: Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction [Phase 1]

  Phase 1 trial of vorinostat in adults with metastatic or unresectable solid tumors or lymphoma and liver dysfunction has completed.

• CLINICAL_TRIALS trial_result · 2012-10-19
  Clinical Trial Update: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1, Phase 2]

  This clinical trial update reports on MDX-010 (ipilimumab) in treating recurrent or refractory lymphoma across multiple subtypes, with the s…